Engineered components manufacturer for critical industries ITT Inc. (NYSE: ITT) beat Wall Street’s revenue expectations in Q1 CY2025, but sales were flat year on year at $913 million. Its non-GAAP profit of $1.45 per share was 0.8% above analysts’ consensus estimates.
Medical technology company Becton, Dickinson and Company (NYSE:BDX) missed Wall Street’s revenue expectations in Q1 CY2025 as sales rose 4.5% year on year to $5.27 billion. On the other hand, the company’s outlook for the full year was close to analysts’ estimates with revenue guided to $21.85 billion at the midpoint. Its non-GAAP profit of $3.35 per share was 2.1% above analysts’ consensus estimates.
Gas handling company Chart (NYSE:GTLS) met Wall Street’s revenue expectations in Q1 CY2025, with sales up 5.3% year on year to $1.00 billion. The company’s full-year revenue guidance of $4.75 billion at the midpoint came in 2.5% above analysts’ estimates. Its non-GAAP profit of $1.86 per share was 1.8% above analysts’ consensus estimates.
When you look at JAZZ PHARMACEUTICALS PLC (NASDAQ:JAZZ), it's hard to ignore the strong fundamentals, especially considering its likely undervaluation.
Global health experts warn that US retreat from TB prevention programs could lead to a resurgence of the deadliest infectious disease, as seen with a recent case in suburban Illinois.
5,500 is a significant technical level for a number of reasons, one of which is that it represents a 50% retracement of all of the losses since the Feb 19 high.
Known for his philosophy of investing in what you know, Peter Lynch looked for companies with consistent earnings growth, low debt, and a competitive edge. Does TECHNIPFMC PLC (NYSE:FTI) meet these key criteria? Let’s find out.
A fundamental and technical analysis of (NYSE:AEM): AGNICO EAGLE MINES LTD (NYSE:AEM) may be suited for high growth investing, we'll explore why in this article.
Beauty products company Estée Lauder (NYSE:EL) announced better-than-expected revenue in Q1 CY2025, but sales fell by 9.9% year on year to $3.55 billion. Its non-GAAP profit of $0.65 per share was significantly above analysts’ consensus estimates.
Galloway advises young people to invest 30% in individual stocks and the rest in index funds. He also stresses the importance of developing a valuable skill and controlling spending.
Electrical supply company WESCO (NYSE:WCC) reported Q1 CY2025 results beating Wall Street’s revenue expectations, but sales were flat year on year at $5.34 billion. Its non-GAAP profit of $2.21 per share was 4.7% below analysts’ consensus estimates.
REGENERON PHARMACEUTICALS has caught the attention as a great value stock. NASDAQ:REGN excels in profitability, solvency, and liquidity, all while being very reasonably priced.
